These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35450324)

  • 1. The Correlation between Matrix Metalloproteinase-9 Point-of-Care Immunoassay, Tear Film Osmolarity, and Ocular Surface Parameters.
    Kang MJ; Kim HS; Kim MS; Kim EC
    J Ophthalmol; 2022; 2022():6132016. PubMed ID: 35450324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Tear Film Osmolarity and 2 Different MMP-9 Tests With Common Dry Eye Tests in a Cohort of Non-Dry Eye Patients.
    Schargus M; Ivanova S; Kakkassery V; Dick HB; Joachim S
    Cornea; 2015 Jul; 34(7):739-44. PubMed ID: 25909238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tear Osmolarity and Matrix Metallopeptidase-9 in Dry Eye Associated with Sjögren's Syndrome.
    Kook KY; Jin R; Li L; Yoon HJ; Yoon KC
    Korean J Ophthalmol; 2020 Jun; 34(3):179-186. PubMed ID: 32495525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel point-of-care biomarkers of the dry anophthalmic socket syndrome: tear film osmolarity and matrix metalloproteinase 9 immunoassay.
    Rokohl AC; Wall K; Trester M; Wawer Matos PA; Guo Y; Adler W; Pine KR; Heindl LM
    Graefes Arch Clin Exp Ophthalmol; 2023 Mar; 261(3):821-831. PubMed ID: 36357674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tear Osmolarity, Break-up Time and Schirmer's Scores in Parkinson's Disease.
    Söğütlü Sarı E; Koç R; Yazıcı A; Şahin G; Çakmak H; Kocatürk T; Ermiş SS
    Turk J Ophthalmol; 2015 Aug; 45(4):142-145. PubMed ID: 27800221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tear osmolarity as a biomarker for dry eye disease severity.
    Suzuki M; Massingale ML; Ye F; Godbold J; Elfassy T; Vallabhajosyula M; Asbell PA
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4557-61. PubMed ID: 20393114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tear Film Osmolarity Measurement in Japanese Dry Eye Patients Using a Handheld Osmolarity System.
    Shimazaki J; Sakata M; Den S; Iwasaki M; Toda I
    Diagnostics (Basel); 2020 Oct; 10(10):. PubMed ID: 33028019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tear film osmolarity in ocular mucous membrane pemphigoid.
    Miserocchi E; Iuliano L; Berchicci L; Bandello F; Modorati G
    Cornea; 2014 Jul; 33(7):668-72. PubMed ID: 24858022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tear Osmolarity and Correlation With Ocular Surface Parameters in Patients With Dry Eye.
    Mathews PM; Karakus S; Agrawal D; Hindman HB; Ramulu PY; Akpek EK
    Cornea; 2017 Nov; 36(11):1352-1357. PubMed ID: 28872518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tear osmolarity measurements in dry eye related to primary Sjögren's syndrome.
    Utine CA; Bıçakçıgil M; Yavuz S; Çiftçi F
    Curr Eye Res; 2011 Aug; 36(8):683-90. PubMed ID: 21780917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tear matrix metalloproteinase-9 levels may help to follow a ocular surface injury in lagophthalmic eyes.
    Minaříková M; Fík Z; Štorm J; Helisová K; Ferrová K; Mahelková G
    PLoS One; 2022; 17(9):e0274173. PubMed ID: 36084126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of tear matrix metalloproteinase 9 immunoassay with signs and symptoms of dry eye disease: A cross-sectional study using qualitative, semiquantitative, and quantitative strategies.
    Lee YH; Bang SP; Shim KY; Son MJ; Kim H; Jun JH
    PLoS One; 2021; 16(10):e0258203. PubMed ID: 34662364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Multi-Ingredient Supplement Reduces Inflammation of the Eye and Improves Production and Quality of Tears in Humans.
    Radkar P; Lakshmanan PS; Mary JJ; Chaudhary S; Durairaj SK
    Ophthalmol Ther; 2021 Sep; 10(3):581-599. PubMed ID: 34129210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tear film osmolarity in patients treated for glaucoma or ocular hypertension.
    Labbé A; Terry O; Brasnu E; Van Went C; Baudouin C
    Cornea; 2012 Sep; 31(9):994-9. PubMed ID: 22710490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A preliminary study on the tear matrix metalloproteinase 9 point-of-care assay using a domestic kit].
    Wan XC; Zhang H; Shen Y; Zhou SY; Yang P; Zhou XJ; Gu H; Le QH; Xu JJ; Zhou XT; Hong JX
    Zhonghua Yan Ke Za Zhi; 2023 Apr; 59(4):272-278. PubMed ID: 37012590
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of tear osmolarity and tear function in patients with Behçet's syndrome.
    Aktaş S; Temiztürk F
    Can J Ophthalmol; 2019 Apr; 54(2):176-179. PubMed ID: 30975340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between tear film osmolarity, dry eye disease, and rheumatoid arthritis.
    Schargus M; Wolf F; Tony HP; Meyer-Ter-Vehn T; Geerling G
    Cornea; 2014 Dec; 33(12):1257-61. PubMed ID: 25255140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between Tear Osmolarity and Other Ocular Surface Parameters in Primary Sjögren's Syndrome.
    Kim M; Kim HS; Na KS
    Korean J Ophthalmol; 2017 Feb; 31(1):25-31. PubMed ID: 28243020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between systemic activity ındex and dry eye severity in patients with primary Sjögren syndrome.
    Ozek D; Kemer OE; Omma A
    Arq Bras Oftalmol; 2019; 82(1):45-50. PubMed ID: 30403265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.